IQVIA Holdings stock surged on Tuesday after the clinical research and analytics company's second-quarter results topped ...

Shares of IQVIA Holdings Inc. IQV slipped 2.97% to $185.86 Thursday, on what proved to be an all-around rough trading session ...

Medpace and Iqvia stocks surged Tuesday after the duo kicked off earnings season with unexpectedly strong reports.

Q2 2025 Earnings Call Transcript July 22, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $2.81, ...

Growth in the Patient Data Hub Solutions Market is driven by healthcare interoperability and IT advancements. Key insights include market segmentation, growth drivers, and Microsoft's AI innovations ...

See the latest IQVIA Holdings Inc stock price (IQV:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Review quarterly and annual revenue, net income, and cash flow for IQVIA Holdings Inc (IQV:XNYS) stock through the last fiscal year.

Contract research firm IQVIA Holdings posted second-quarter profit and revenue above Wall Street expectations on Tuesday, as demand rose for its healthcare data and analytics services, sending shares ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and ...

He joined IQVIA in 2003 and has been rising up the ranks ever since, from director of stats to leading a team over more than 50 to incorporate artificial intelligence into the company’s suite of ...

Iqvia Holdings Inc. IQV 3.62% is hardly a household name, but its boss made more last year than the chief executive of Johnson & Johnson —or any other big pharmaceutical or biotech company.